FDA Stresses Early Discussion Of Foreign Data In Post-MDUFMA World
This article was originally published in The Gray Sheet
Executive Summary
CDRH is urging sponsors to schedule pre-filing meetings with the device center, especially if firms plan to use data collected in trials conducted outside the U.S